DongKook Pharmaceutical Co., Ltd. (KOSDAQ: 086450)

DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 203.54B KRW in the quarter ending June 30, 2024, with 9.50% growth. This brings the company's revenue in the last twelve months to 764.67B, up 10.38% year-over-year. In the year 2023, DongKook Pharmaceutical had annual revenue of 730.99B with 10.48% growth.

• Revenue (ttm): 764.67B
• Revenue Growth: +10.38%
• P/S Ratio: 1.01
• Revenue / Employee: 685.19M
• Employees: 1,116
• Market Cap: 772.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	559.10B	76.82B	15.93%
Dec 31, 2019	482.28B	81.47B	20.33%